PT  - JOURNAL ARTICLE
AU  - Stier, Andrew J.
AU  - Berman, Marc G.
AU  - Bettencourt, Luis M. A.
TI  - COVID-19 attack rate increases with city size
AID  - 10.1101/2020.03.22.20041004
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.03.22.20041004
4099  - http://medrxiv.org/content/early/2020/04/03/2020.03.22.20041004.short
4100  - http://medrxiv.org/content/early/2020/04/03/2020.03.22.20041004.full
AB  - The current outbreak of novel coronavirus disease 2019 (COVID-19) poses an unprecedented global health and economic threat to interconnected human societies. Until a vaccine is developed, strategies for controlling the outbreak rely on aggressive social distancing. These measures largely disconnect the social network fabric of human societies, especially in urban areas. Here, we estimate the growth rates and reproductive numbers of COVID-19 in US cities from March 14th through March 19th to reveal a power-law scaling relationship to city population size. This means that COVID-19 is spreading faster on average in larger cities with the additional implication that, in an uncontrolled outbreak, larger fractions of the population are expected to become infected in more populous urban areas. We discuss the implications of these observations for controlling the COVID-19 outbreak, emphasizing the need to implement more aggressive distancing policies in larger cities while also preserving socioeconomic activity.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research is partially supported by the Mansueto Institute for Urban Innovation and a Social Science Research grant from the University of Chicago.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCOVID-19 case data by county is available at https://github.com/tomquisel/covid19-data. US Census population data is available at https://www.census.gov/data/tables/time-series/demo/popest/2010s-counties-total.html. MSA delineation files are available at https://www.census.gov/programs-surveys/metro-micro/about/delineation-files.html. https://www.census.gov/programs-surveys/metro-micro/about/delineation-files.html https://www.census.gov/data/tables/time-series/demo/popest/2010s-counties-total.html https://github.com/tomquisel/covid19-data